Resources


Advanced



 Quick Order
  This area of the site
   requires the
  Acrobat Reader
  and the ability to
  view zipped files.
  Click below to
  download the
   necessary
   software.
  The StuffIt
   software can be
   used for either
   Windows or
   Macintosh.


Download the Adobe Acrobat reader

Download the StuffIt Expander

Download WinZip

 
 
Slide Lecture Programs
2006 Core Curriculum
Antiplatelet Interventions in ACS
March 10, 2006

II:  Thrombus Susceptibility and the Vulnerable Plaque" width="220" height="147" border="0">

Thrombus Susceptibility and the Vulnerable Plaque
 
 
18
  Slide: 18 - Interaction between inflammation and hemostasis in vulnerable plaque</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Interaction between inflammation and hemostasis in vulnerable plaque
 
 
19
  Slide: 19 - Txnip links shear stress to inflammation</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Txnip links shear stress to inflammation
 
 
20
  Slide: 20 - Platelet adhesion and aggregation</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Platelet adhesion and aggregation
 
 
21
  Slide: 21 - Platelets release soluble CD40 ligand (sCD40L) after thrombin stimulation</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Platelets release soluble CD40 ligand (sCD40L) after thrombin stimulation
 
 
22
  Slide: 22 - Recombinant sCD40L enhances platelet release of reactive oxygen species</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Recombinant sCD40L enhances platelet release of reactive oxygen species
 
 
23
  Slide: 23 - GP IIb/IIIa antagonists block sCD40L release from platelets</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

GP IIb/IIIa antagonists block sCD40L release from platelets
 
 
24
  Slide: 24 - Points of action for antithrombotics</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Points of action for antithrombotics
 
 
25
  Slide: 25 - Proposed model for optimal use of GP IIb/IIIa inhibitors</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Proposed model for optimal use of GP IIb/IIIa inhibitors
 
 
26
  Slide: 26 - Potential mechanisms for reduction of thrombo-inflammation with GP IIb/IIIa inhibition</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Potential mechanisms for reduction of thrombo-inflammation with GP IIb/IIIa inhibition
 
 
<< previous      next >>

Home | Literature Update | Journal Link | Resources | Meeting Highlights | Members | About VBWG | Web Links